TeSR™-AOF: Designing a Product for the Future
Hear how TeSR™-AOF ticks all the boxes for successful quality and risk assessment on your path to the clinic. Scientist Kimberly Snyder discusses TeSR™-AOF’s optimized performance compared to low protein media and Lynn Csontos, Senior Director for Quality Assurance and Regulatory Affairs, explains its enhanced safety profile.
Publish Date:
July 28, 2021
Request Pricing
Thank you for your interest in this product. Please provide us with your contact information and your local representative will contact you with a customized quote. Where appropriate, they can also assist you with a(n):
Estimated delivery time for your area
Product sample or exclusive offer
In-lab demonstration
By submitting this form, you are providing your consent to STEMCELL Technologies Canada Inc. and its subsidiaries and affiliates (“STEMCELL”) to collect and use your information, and send you newsletters and emails in accordance with our privacy policy. Please contact us with any questions that you may have. You can unsubscribe or change your email preferences at any time.
Related Multimedia
-
TeSR™-AOF Data Overview
Publish Date: January 18, 2021 -
Lost in Translation - Moving Your Research to Clinical Trials
Publish Date: May 14, 2021 -
Nature Research Round Table: hPSC Lines for Cell Therapies - Panel Discussion
Publish Date: November 01, 2019
Explore Our Products
-
cGMP, animal origin-free, stabilized, feeder-free maintenance medium for human ES and iPS cells
